A Phase 1, Randomized, Study in Healthy Volunteers to Assess Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654
Latest Information Update: 14 May 2024
At a glance
- Drugs Nuvisertib (Primary)
- Indications Myelofibrosis
- Focus Pharmacokinetics
- Sponsors Sumitomo Pharma America
Most Recent Events
- 03 May 2024 New trial record